MIURA Satoru 三浦理

Researcher Number	70420320
Affiliation (based on the past Project Information) *help	2017: 新潟大学, 医歯学総合病院, その他 2014 – 2016: 新潟大学, 医歯学総合病院, 特任助教 2013 – 2014: 新潟大学, 医歯学総合病院, 助教 2012: 新潟大学, 医歯学総合病院, 医員
Review Section/Research Field	Except Principal Investigator Respiratory organ internal medicine
Keywords	Except Principal Investigator lymphodepletion / adoptive immunotherapy / Adoptive immunotherapy / PD-L1 / T細胞 / PD-1 / 免疫療法 / regulatory T cells / tumor immunotherapy / regulatory T cell … More / 細胞療法 / 腫瘍免疫療法 / 抑制性T細胞 / 肺癌 / 腫瘍免疫 / lung cancer / Regulatory T cells / Tumor immunotherapy Less

Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancer
- Principal Investigator
  
  Watanabe Satoshi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunity
- Principal Investigator
  
  WATANABE Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University

All 2016 2015 2012

All Journal Article Presentation

[Journal Article] Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.2016
- Author(s)
  Ko Sato, Satoshi Watanabe,corresponding author Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, and Ichiei Narita
- Journal Title
  
  BMC Cancer
  
  Volume: 16(1) Issue: 1 Pages: 222-222
- DOI
  10.1186/s12885-016-2271-8
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25860637, KAKENHI-PROJECT-26293196, KAKENHI-PROJECT-15K09168
[Journal Article] Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.2015
- Author(s)
  Miura S, Watanabe S (他12名8番目）
- Journal Title
  
  Internal medicine
  
  Volume: 54 Pages: 55-58
- NAID
  130004902998
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.2015
- Author(s)
  Saida Y, Watanabe S, Tanaka T, Baba J, Sato K, Shoji S, Igarashi N, Kondo R, Okajima M, Koshio J, Ichikawa K, Nozaki K, Ishikawa D, Koya T, Miura S, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I
- Journal Title
  
  Journal of immunology
  
  Volume: 195 Pages: 726-735
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Journal Article] Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.2012
- Author(s)
  Ichikawa K, Kagamu H, Koyama K, Miyabayashi T, Koshio J, Miura S, Watanabe S, Yoshizawa H, Narita I.
- Journal Title
  
  Vaccine
  
  Volume: 30 Pages: 6190-6197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.2012
- Author(s)
  Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I.
- Journal Title
  
  Blood
  
  Volume: 120 Pages: 2417-2427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation2015
- Author(s)
  Ko Sato, Satoshi Watanabe, Yu Saida, Tomohiro Tanaka, Junko Baba, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  Annual meeting of american association for cancer research
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  American assocation of cancer research
- Place of Presentation
  Chicago, USA
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Combination of cyclophosphamide and inhibition of chemo-resistant　suppressor cells successfully treated advanced tumors.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  日本癌学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24591157

1. WATANABE Satoshi (50529740)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
2. KAGAMU Hiroshi (30418686)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
3. YOSHIZAWA Hirohisa (50282984)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
4. NAKATA Ko (80207802)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
5. 岡島正明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

MIURA Satoru 三浦 理

Research Projects

Research Products

Co-Researchers

Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunity

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.2015

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.2015

Author(s)

Journal Title

Data Source

[Journal Article] Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.2012

Author(s)

Journal Title

Data Source

[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.2012

Author(s)

Journal Title

Data Source

[Presentation] Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells.2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Combination of cyclophosphamide and inhibition of chemo-resistant suppressor cells successfully treated advanced tumors.2012

Author(s)

Organizer

Place of Presentation

Data Source

MIURA Satoru 三浦理

[Presentation] Combination of cyclophosphamide and inhibition of chemo-resistant　suppressor cells successfully treated advanced tumors.2012